Since CYP1B1 is involved in the metabolism of catechol estrogen and the formation of a toxicologically active metabolite, 4-hydroxyestradiol, the inhibition of CYP1B1 is an attractive target for hormonally driven cancers such as breast. This evidence concerns the gene CYP1B1 and cancer.